Patents by Inventor Edwin Samuel Johnson

Edwin Samuel Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of a mammary or DMBA inducible tumor
    Patent number: 4071622
    Abstract: Certain nonapeptide amides were found which, upon administration at daily dosages of from about 1-200 .mu.g/kg to warm-blooded animals, cause regression of DMBA-inducible or mammary tumors without causing adverse effects on healthy tissues.
    Type: Grant
    Filed: February 11, 1976
    Date of Patent: January 31, 1978
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, John Hunter Seely
  • Method to prevent reproduction in warm-blooded female animals with nonapeptides
    Patent number: 4034082
    Abstract: With the administration of 1 .mu.g - 10mg/kg of specified nonapeptides, reproduction is prevented in warm-blooded animals of the reproductive age.
    Type: Grant
    Filed: March 1, 1976
    Date of Patent: July 5, 1977
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, Wilfrid Francis White
  • Parturition inducement
    Patent number: 4018914
    Abstract: Certain nonapeptides have been found to induce parturition in warm-blooded animals if administered within the last phase of pregnancy.
    Type: Grant
    Filed: November 13, 1975
    Date of Patent: April 19, 1977
    Assignee: Abbott Laboratories
    Inventor: Edwin Samuel Johnson
  • Method to prevent reproduction with [Des-Gly].sup.10 -GN-RH nonadeptide amide analogs in position
    Patent number: 4010261
    Abstract: With the administration of 2 - 200 .mu.g./kg. of a nonapeptide, reproduction is prevented in warm-blooded animals of the reproductive age.
    Type: Grant
    Filed: November 25, 1974
    Date of Patent: March 1, 1977
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, Riemond Henry Rippel, Jr.
  • Treatment of prostatic hyperplasia
    Patent number: 4005194
    Abstract: A series of nonapeptide amides has been found which, upon administration at daily doses of from about 1-500 .mu.g/kg to male warm-blooded animals, cause regression and subsequent elimination of prostatic hyperplasia without causing adverse effects to healthy tissues.
    Type: Grant
    Filed: June 23, 1975
    Date of Patent: January 25, 1977
    Assignee: Abbott Laboratories
    Inventor: Edwin Samuel Johnson
  • Treatment of specified neoplasias
    Patent number: 4002738
    Abstract: A series of nonapeptide amides has been found which, upon administration at daily dosages of from about 1-200 .mu.g/kg to warm-blooded animals, cause regression and subsequent elimination of certain tumors without causing adverse effects on healthy tissues.
    Type: Grant
    Filed: May 30, 1975
    Date of Patent: January 11, 1977
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, John Hunter Seely